These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Treatment of disequilibrium and nausea in the SRI discontinuation syndrome. Schechter JO J Clin Psychiatry; 1998 Aug; 59(8):431-2. PubMed ID: 9721826 [No Abstract] [Full Text] [Related]
6. Withdrawal after discontinuation of paroxetine. Arya DK Aust N Z J Psychiatry; 1996 Oct; 30(5):702. PubMed ID: 8902183 [No Abstract] [Full Text] [Related]
7. Hallucination induced by paroxetine discontinuation in patients with major depressive disorders. Yasui-Furukori N; Kaneko S Psychiatry Clin Neurosci; 2011 Jun; 65(4):384-5. PubMed ID: 21489048 [TBL] [Abstract][Full Text] [Related]
16. A randomized, double-blind, 24-week study comparing the efficacy and tolerability of mirtazapine and paroxetine in depressed patients in primary care. Wade A; Crawford GM; Angus M; Wilson R; Hamilton L Int Clin Psychopharmacol; 2003 May; 18(3):133-41. PubMed ID: 12702891 [TBL] [Abstract][Full Text] [Related]
17. Minor strokes related to paroxetine discontinuation in an elderly subject: emergent adverse events. Ramasubbu R Can J Psychiatry; 2003 May; 48(4):281-2. PubMed ID: 12776398 [No Abstract] [Full Text] [Related]